Alzheimer's Disease Phase I Clinical Trials (R01)Funding Number: RFA-AG-13-016
Release Date: October 15, 2012
Expiration Date: January 15, 2013
Web Site: http://grants.nih.gov/grants/guide/rfa-files/RFA-AG-13-016.html
The objective of the Alzheimer's Disease Phase I Clinical Trials initiative is to provide support for first-in-human studies for promising Alzheimers disease therapeutics. These first stage clinical trials will evaluate the metabolic and pharmacological actions of drugs, including biologics in humans.